STOFF 2023

STOFF 2023 presented a unique opportunity for oncology fellows and emerging cancer research scientists to connect with professionals engaged in multidisciplinary and interprofessional translational research. The Forum delivered an immersive curriculum of dynamic presentations, interactive roundtable discussions, and numerous networking opportunities, facilitated by a panel of distinguished faculty members.

Participants reported a significantly enriched understanding of the pivotal role of translational research in clinical medicine, the intricacies of drug development within oncology, and the foundational aspects of grant writing and robust research methodologies. The mentorship, faculty guidance, and strategic insights for nurturing peer networks among fellow oncologists are crucial elements that will continue to drive the progress of these Fellows’ translational research efforts in oncology.

Heartfelt congratulations to our 2023 Fellows, now part of an esteemed community comprising over 665 physicians and scientists proudly carrying the title of STOFF alumni!

"In summary, the STOFF workshop stands as a pivotal milestone in my journey toward advancing my skills and expertise in the realm of translational research. I firmly believe that the STOFF workshop aligns exceptionally well with its stated mission of "Educating young oncologists in the field of clinical and translational research." I highly recommend the STOFF workshop to fellows who aspire to enhance and cultivate their proficiency in translational research."
James Yu
"To encapsulate, Dr. Engelman's lecture was more than just a presentation; it was a panoramic voyage into the multifaceted world of cancer drug development. It captured the essence of innovation, the challenges of targeted research, and the unwavering commitment required to navigate the intricate nuances of drug design, delivery, and efficacy."
Yumeng Zhang

2023 STOFF Fellows

Amir Ameri, MD, Johns Hopkins Medicine
Eric Bent, MD, PhD, Harvard Medical School
Rahul Bhansali, MD, Hospital of the University of Pennsylvania
Julia Blanter, MD, Icahn School of Medicine at Mount Sinai
Raju Chelluri, MD, MS, Fox Chase Cancer Center
Heidy Cos Felipe, MD, Washington University in St Louis
Ayse Ece Cali Daylan, MD, PhD, Montefiore Medical Center
Kunal Desai, MD, MBA, MS, University of Chicago
Oluwadunni Emiloju, MDDS, MS, Mayo Clinic College of Medicine

Takeo Fujii, MD, MPH, Northwell Health Cancer Institute | Cold Spring Harbor Laboratory
Yiduo Ian Hu, MD, PhD, BSc, Yale School of Medicine
Kohsuke Isomoto, MD, PhD,  Kindai University
Adriana Kahn, MD, Yale University
Asuka Kawachi, MD, National Cancer Center Hospital (NCCH)
Katie N. Lee, MD, PhD, Harvard Medical School
Abu-Sayeef Mirza, MD, MPH, FACP, Yale University
Tarek H. Mouhieddine, MD, Icahn School of Medicine at Mount Sinai

Curt Perry, MD, PhD, Yale New Haven Hospital
Dionisia Marie Quiroga, DO, PhD, Ohio State University
Nathaniel Robinson, MD, Yale School of Medicine
Joshua Smith, MD, University of Michigan
Masahiro Uni, MD, PhD, Memorial Sloan Kettering Cancer Center
Norihiro Yamaguchi, MD, MPH, PhD, National Institutes of Health
James Yu, MD, University of South Florida
Yumeng Zhang, MD, University of South Florida

This activity was supported by educational grants from:
  • Chugai Foundation for Innovative Drug Discovery Science
  • Coherus BioSciences
  • Janssen Biotech, Inc.
  • Lilly
  • Pfizer